Dr. Stephenson on Advancements of Treatment for Prostate Cancer

Andrew J. Stephenson, MD
Published: Wednesday, Aug 09, 2017



Andrew J. Stephenson, MD, director for the Center of Urologic Oncology at the Cleveland Clinic, discusses advancements being made in the field of prostate cancer.

A challenge that needs to be addressed is the ability to determine which cancers will be aggressive and require a more intense treatment, explains Stephenson. There are a lot of developments in the areas of imaging, genomics, and biomarkers that will help to answer this question.

Additionally, for men with more aggressive cancers, there are emergences of new treatment paradigms, states Stephenson.
 


Andrew J. Stephenson, MD, director for the Center of Urologic Oncology at the Cleveland Clinic, discusses advancements being made in the field of prostate cancer.

A challenge that needs to be addressed is the ability to determine which cancers will be aggressive and require a more intense treatment, explains Stephenson. There are a lot of developments in the areas of imaging, genomics, and biomarkers that will help to answer this question.

Additionally, for men with more aggressive cancers, there are emergences of new treatment paradigms, states Stephenson.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Publication Bottom Border
Border Publication
x